Voluntary nationwide recall: Potassium (Glenmark – June)

Jul. 2024Pharmacy Updates

Glenmark Pharmaceuticals Inc. is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. Potassium Chloride is used for the treatment of low potassium.

This drug is being recalled because the product failed to dissolve in the body. This may cause high potassium levels, which can result in irregular heartbeat that can lead to cardiac arrest.

As of the date of Glenmark’s recall announcement, June 24, 2024, there have been no reports of adverse events related to this recall. Consult your health care provider before you stop using this product. To see if your medication was recalled, contact your doctor or pharmacy where you received the medication or visit the FDA website below.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Inmar Rx Solutions at 1-877-883-9273. TTY users should call 711. Help is available Monday through Friday from 9 a.m. to 5 p.m. EST.
  • Visit the FDA website.

Recent Announcements

Medicaid Renewal

 Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.
Aug. 2026Important Notices

Provider Directory Updates and Required Attestation

As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).
Aug. 2026Important Notices

Voluntary nationwide recall: Tyenne (Fresenius – August 2026)

Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.
Aug. 2026Pharmacy Updates